Webinars and Sponsored Roundtables — Register Now
Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.
Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy, CEO of mTuitive.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Tuesday, June 9, 2026, 1:00–2:00 PM ET
In this webinar, we will examine how immune recognition after allogeneic HCT can influence leukemia relapse and disease progression. The session will highlight the clinical relevance of HLA loss of heterozygosity (LOH), approaches used for its detection, and how LOH findings may support transplant strategies, including considerations for donor selection in subsequent transplantation.
Webinar presenter Alberto Cardoso Martins Lima, PhD, Clinical consulting scientist in histocompatibility,
specializing in allogeneic hematopoietic cell transplantation (HCT) at IGEN/AFIP São Paulo and CHC/UFPR in Curitiba, Brazil
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, June 24, 2026, 12:00–1:00 PM ET
Hear an expert discuss the expanded clinical utility of HER2 IHC scoring in metastatic breast cancer and its impact on your practice
Webinar presenter Michelle Shiller, DO, AP, CP, MGP, FACP, Baylor University Medical Center.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Subspecialties
Interactive Product Guides
Product Spotlight
Beckman Coulter
| Company | Beckman Coulter |
|---|---|
| Name of instrument | DxC 500i Clinical Analyzer |
| City, State | Brea, CA |
| Phone | 800-526-3821 |
| Website | |
| Type of instrument | combination chemistry/immunoassay |
| Operational type/Model type | continuous random access/floor standing |
| List price/First year sold in U.S. | —/2025 |
| Targeted hospital bed size/Targeted | —/annual: 50, 000–350, 000 |
| Company manufactures instrument | yes (also sold by distribution partners) |
| Other models in this family of analyzers | DxC 500 AU, DxC 700 AU, AU5800, Access 2, DxI 600, DxI 9000 |
| No. of units in clinical use in U.S./Outside U.S. (countries) | —/— (worldwide) |
| Dimensions (H × W × D)/Instrument footprint | 48.8 × 100 × 30.3 in./21 sq. ft. |
| Weight empty/Weight fully loaded | 1, 430 lbs./— |
| No. of different measured assays onboard simultaneously | — |
| No. of user-definable (open chemistry) channels | — |
| Test throughput per hour/Assay run time | 800 chemistry with ISE, 100 immunoassay/— |
| No. of direct ion-selective electrode channels | — |
| Detection methods | photometry, potentiometry |
| • Ion-selective electrode | — |
| • Basic metabolic panel | — |
| • Complete metabolic panel | — |
| Typical time delay from ordering stat test until aspiration of sample | — |
| Fully automated microplate immunoassay system | no |
| Methodologies supported | chemiluminescence |
| Separation methodologies | — |
| Stat time until completion of a ß-hCG test | — |
| Stat time until completion of a cTn test | — |
| • Typical time delay from test order to aspiration of sample | — |
| Approximate No. of tests per reagent set/Reagent type | 50–6, 744 per pack (varies by assay)/— |
| Reagents refrigerated onboard/Reagents ready to use | yes (4.5°–12°C)/variable; reagent specific |
| Reagent lot tracking/Reagent inventory | yes/yes |
| Reagent form/Reagents barcoded | liquid chemistry (open reagent system)/yes |
| Separate reagent pack for each specimen/for each test run | no/no |
| Walkaway capability/Walkaway duration | yes/168 specimens |
| Design of sample-handling system | rack |
| Uses washable cuvettes/Uses disposable cuvettes | yes (can store up to 88 cuvettes)/no |
| Min.–max. sample volume that can be aspirated at one time | 1–25 µL |
| Min. reaction volume/Min. specimen volume/Min. dead volume | 90 µL/50 µL/80 µL |
| Dedicated pediatric sample cup | no |
| Primary tube sampling | yes |
| Accommodates most standard tube sizes/Accepts nonstandard tube sizes | yes/— |
| Pierces caps on primary tubes | no |
| Protects against probe collision | yes |
| Detects clots/liquid level/short sample | yes/yes/yes |
| Detection or quantitation for hemolysis, icterus, lipemia, clots | detection for hemolysis, icterus, lipemia, clots |
| Dilutes patient samples onboard/Susceptibility to carryover | yes (can be programmed to perform dilutions prior to analysis)/— |
| Automatic rerun capability | yes |
| Sample volume can be concentrated to rerun out-of-linear-range low results | yes |
| Analyzer requires dedicated water supply | yes (10 L/hr. consumption during operation) |
| Autocalibration/Multipoint calibration supported | yes (calibrants are not stored onboard)/yes |
| Typical calibration frequency for ISE/therapeutic drugs/drugs of abuse/general chemistries/immunoassays | 1 day/—/—/1–90 days/— |
| Automatic programmable start/Automatic programmable shutdown | — |
| Onboard real-time QC/Onboard software capability to review QC | yes/yes |
| Supports multiple QC lot numbers per analyte | yes |
| Waste management | direct to drain |
| Sample barcode-reading capability/Autodiscrimination | yes (Interleaved 2 of 5, Code 39, Code 128, NW7, EAN-13, ISBT 128, Standard 2 of 5)/— |
| Lab can control analyzer from remote computer | yes |
| Instrument can diagnose its own malfunctions | yes (instrument can order malfunctioning parts) |
| System malfunctions can be diagnosed via remote monitoring | yes |
| UPS backup power supply | yes |
| Data-management capability/LIS or EHR systems interfaced | onboard/Medicus, Orchard, Evident, CGM LabDaq, Cerner, Sunquest |
| LIS interface provided/Bidirectional interface capability | yes (additional cost)/yes (host query) |
| Modem servicing provided/Service engineer on-site response time | — |
| Mean time between failures | — |
| Average scheduled maintenance time by lab personnel | daily: 9 min.; weekly: 26 min.; monthly: 45 min. |
| Maintenance records kept onboard for user/vendor | no/no |
| Maintenance training demonstration module onboard | yes |
| Training included with purchase/Avg. time for basic user training | yes (2 training slots)/— (at customer site) |
| Advanced operator training/Extra charge for follow-up or advanced training | yes (at vendor site)/— |
| Warranty provided/Cost of annual service contract (24 h/7 d) | — |
| Distinguishing features (supplied by company) | independent and integrated operations, reagent load on the fly, rapid throughput; single point of sample loading, intuitive interface and guided workflows, easy to maintain parts; offers a menu of more than 170 assays for complete disease state management |